Outcome of patients treated with pentostatin as salvage therapy of steroid refractory acute intestinal graft-versus-host disease

被引:0
|
作者
Klein, SA [1 ]
Bug, G [1 ]
Wassmann, B [1 ]
Hoelzer, D [1 ]
Martin, H [1 ]
机构
[1] Univ Frankfurt Klinikum, D-6000 Frankfurt, Germany
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S180 / S180
页数:1
相关论文
共 50 条
  • [31] EXTRACORPOREAL PHOTOPHERESIS: EFFECTIVE THERAPY FOR STEROID DEPENDENT AND REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
    Jacobs, R. W.
    Jagasia, M. H.
    Savani, B. N.
    Neff, A. T.
    Engelhardt, B. G.
    Goodman, S.
    Greer, J. P.
    Proctor, K.
    Schuening, F.
    Russell, N. H.
    Das-Gupta, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S222 - S222
  • [32] Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease
    Kyohei Isshiki
    Takahiro Kamiya
    Akifumi Endo
    Kentaro Okamoto
    Tomoo Osumi
    Toshinao Kawai
    Katsuhiro Arai
    Daisuke Tomizawa
    Kazuo Ohtsuka
    Masakazu Nagahori
    Kohsuke Imai
    Motohiro Kato
    Hirokazu Kanegane
    International Journal of Hematology, 2022, 115 : 590 - 594
  • [33] Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease
    Melgarejo-Ortuno, Alejandra
    Escudero-Vilaplana, Vicente
    Luis Revuelta, Jose
    Bailen, Rebeca
    Collado-Borrell, Roberto
    Gomez-Centurion, Ignacio
    Oarbeascoa, Guillen
    Kwon, Mi
    Heranz, Ana
    Luis Diez-Martin, Jose
    Sanjurjo, Maria
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 751 - 755
  • [34] Intra-arterial steroid therapy for steroid refractory graft-versus-host disease
    Madeira, MI
    Favarin, MC
    Pieroni, F
    Stracieri, AB
    Oliveira, MC
    Moraes, D
    Voltarelli, JC
    Simoes, BP
    BONE MARROW TRANSPLANTATION, 2006, 37 : S98 - S99
  • [35] Rituximab as salvage therapy for refractory sclerodermatous chronic graft-versus-host disease
    Namdaroglu, S.
    Iskender, D.
    Dal, M. S.
    Cakar, M. K.
    Tekgunduz, E.
    Altuntas, F.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2019, 27 (01): : 12 - 18
  • [36] Pentostatin Therapy for Steroid-Refractory Acute Graft Versus Host Disease: Identifying Those Who May Benefit
    Ragon, Brittany Knick
    Gulbis, Alison M.
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Popat, Uday R.
    Nieto, Yago
    Oran, Betul
    Olson, Amanda L.
    Patel, Krina
    Hosing, Chitra M.
    Qazilbash, Muzaffar H.
    Shah, Nina
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Alousi, Amin M.
    BLOOD, 2015, 126 (23)
  • [37] Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-versus-Host Disease
    Sanchez-Ortega, Isabel
    Servitje, Octavio
    Arnan, Montserrat
    Orti, Guillermo
    Peralta, Teresa
    Manresa, Federico
    Duarte, Rafael F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : 318 - 323
  • [38] Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit
    Ragon, Brittany Knick
    Mehta, Rohtesh S.
    Gulbis, Alison M.
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Popat, Uday R.
    Nieto, Yago
    Oran, Betul
    Olson, Amanda L.
    Patel, Krina
    Hosing, Chitra M.
    Qazilbash, Muzaffar H.
    Shah, Nina
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Alousi, Amin M.
    BONE MARROW TRANSPLANTATION, 2018, 53 (03) : 315 - 325
  • [39] Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit
    Brittany Knick Ragon
    Rohtesh S. Mehta
    Alison M. Gulbis
    Rima M. Saliba
    Julianne Chen
    Gabriela Rondon
    Uday R. Popat
    Yago Nieto
    Betul Oran
    Amanda L. Olson
    Krina Patel
    Chitra M. Hosing
    Muzaffar H. Qazilbash
    Nina Shah
    Partow Kebriaei
    Elizabeth J. Shpall
    Richard E. Champlin
    Amin M. Alousi
    Bone Marrow Transplantation, 2018, 53 : 315 - 325
  • [40] Daclizumab therapy improves outcome in steroid refractory acute graft versus host disease (aGVHD).
    Doocey, RT
    Greenwood, MJ
    Warkentin, D
    Song, KW
    Le, A
    Nitta, J
    Nevill, TJ
    Barnett, MJ
    Forrest, DL
    Hogge, DE
    Lavoie, JC
    Nantel, SH
    Shepherd, JD
    Sutherland, HJ
    Toze, CL
    Smith, CA
    BLOOD, 2004, 104 (11) : 356B - 356B